SOW FHP Component 7_ 31 March 2022.pdf
PDF 41 KB Posted
- Attached to
- Pacific Region Force Health Protection (FHP) Vector-borne Disease Agent Surveillance, Kadena AB, Japan
- Solicitation number
- FA527022Q0052
View the file
Other files
| File | Type | Posted |
|---|---|---|
| Combined Synopsis-Solicitation FA527022Q0052_FHP Surveillance.pdf |
On GovTribe
Work with this file
- Download the original file
- Contacts named in this file
- Similar government files
- Ask GovTribe AI about this file
Text version
Statement of Work, Attachment 1
Statement of Work for
Pacific Region Force Health Protection Vector-borne Disease Agent
Surveillance, Component 7
Kadena Air Base, Japan
March 31, 2022
Statement of Work: Table of Contents
SECTION PAGE
1. General Services Description 2
2. Task List 3
3. Expenses 3
4. Submittals 3
5. Quality Assurance (QA) Provision 3
6. Force Majeure 3
1. General Services Description
The contractor shall conduct nucleic acid preparation and analyses from mosquito and tick lysate samples provided by the 18 Operational Medical Readiness Squadron, Theater Preventive Medicine
Flight, Kadena Air Base, Okinawa, Japan according to the Statement of Work (SOW). The contractor shall conduct nucleic preparation and analyses not to exceed a maximum combined grand total of 380 mosquito and tick lysate samples and not to exceed a maximum combined grand total of 760 analytical tests from all collection locations combined. Contractor analytical capabilities that may be applied include: pan flavivirus and pan alphavirus RT-PCR assays; Japanese encephalitis virus (JEV), dengue virus (DENV), Zika virus (ZIKV), chikungunya virus (CHIKV) RT-PCR assays; Plasmodium spp (P.
spp) PCR assay; Rickettsia spp PCR assay. Confirmation testing of RT-PCR/PCR putative positive samples shall be accomplished using nucleic acid sequence analyses. Mosquito and tick collection sites listed here may be adapted to evolving FHP priorities;
1.1 Objectives:
Analyze mosquito and tick lysate samples for the presence of pathogens. Lysate samples will be provided to the contractor from the following locations:
a. Kadena AB, Japan
b. Yokota AB, Japan
c. Misawa AB, Japan
d. Andersen AB Guam
e. Osan AB, Korea
f. Kunsan AB, Korea
g. Utapao Royal Thai AB, Thailand
h. Paya-lebar AB, Singapore
i. Clark AB, Philippines
j. Contingency Airfield
1.2 Requesting Members
Primary OPR
Lt Col Mark Olson
Theater Preventive Medicine Flight
18 Operational Medical Readiness Squadron
Kadena AB Japan mark.f.olson.mil@mail.mil
315-634-2639
Budget Analyst
Ms. Mika Kinjo
Theater Preventive Medicine Flight Resource Manager
18 Operational Medical Readiness Squadron
Kadena AB Japan mika.kinjo.1.jp@us.af.mil
315-634-0299
2. TASK LIST
2.1 Task 1
Contractor shall, from 18 Operational Medical Readiness Squadron provided mosquito and tick lysate samples, conduct nucleic preparation and RT-PCR/PCR analyses not to exceed a maximum combined grand total of 380 mosquito and tick lysate samples and not to exceed a maximum combined grand total of 760 analytical tests from all collection locations combined.
2.2 Task 2
Contractor shall, conduct nucleic acid sequence analyses of RT-PCR/PCR putative positive mosquito and tick lysate samples.
2.3 Task 3
Contractor shall, provide analytical results as those data become available and final report 10 days prior to the end of period of performance.
3. EXPENSES
3.1 CONTRACTOR INCURRED EXPENSES. All expenses incurred by Contractor and employees while executing this Pacific Region Force Health Protection Vector-borne Disease Agent Surveillance contract will be the responsibility of the Contractor, and thus considered as include in provided pricing quote.
3.1.1 TRAVEL
Travel is not requested from the Contractor.
3.1.2 MISCELLANEOUS EXPENSES.
Contractor will be responsible for all other miscellaneous expenses to execute task list.
4. SUBMITTALS.
Contractor will submit the required procedures, plans, and reports according to the Task List.
5. QUALITY ASSURANCE (QA) PROVISIONS
5.1 Test and Inspections
The contractor shall submit for Government-review and approval, a laboratory quality assurance management plan to include procedural steps that utilize both positive and negative controls to ensure test results.
5.2 DISCREPANCIES
The Government reserves the right to refuse final acceptance until all discrepancies have been resolved
(to the satisfaction of the Government). The Government will review all test results and prepare a list of discrepancies, if any. The discrepancy list shall include any problem(s) detected/identified during testing or inspection conducted by either the contractor or Government, or both.
6. FORCE MAJEURE
Neither Party will be liable for any failure or delay in performing an obligation under this SOW that is due to any of the following causes, to the extent beyond its reasonable control: acts of God, accident, riots, war, terrorist act, epidemic, pandemic (including the COVID-19 pandemic), quarantine, civil commotion, breakdown of communication facilities, breakdown of web host, breakdown of internet service provider, natural catastrophes, governmental acts or omissions, changes in laws or regulations, national strikes, fire, explosion, or generalized lack of availability of raw materials or energy.
File details come from the government source that posted it. Updated .